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OBJECTIVE: To compare the effects of hydrophobic and hydrophilic materials in square-edged acrylic intraocular
lenses (IOLs) on the development of posterior capsule opacification (PCO) after pediatric cataract surgery.
METHODS: Patients were randomly assigned to group 1 (hydrophobic acrylic square-edged IOLs; 13 eyes) or group
2 (hydrophilic acrylic square-edged IOLs; 13 eyes). The study evaluated PCO rates using Evaluation of Posterior
Capsule Opacification (EPCO) 2000 software at one, three, six and 12 months postoperatively. Postoperative
measurements also included corrected distance visual acuity (CDVA), neodymium:yttrium-aluminum-garnet
(Nd:YAG) capsulotomy and postoperative complications other than PCO.
RESULTS: Both groups had significant increases in PCO rates after one year. Comparison of the groups showed
no significant differences in the EPCO scores at three (group 1, 0.007±0.016 vs group 2, 0.008±0.014;
p=0.830), six (group 1, 0.062±0.103 vs group 2, 0.021±0.023; p=0.184), or twelve months postoperatively
(group 1, 0.200±0.193 vs group 2, 0.192±0.138; p=0.902). We also found no significant group differences
regarding the change (delta, D) in EPCO scores between three and six months (group 1, 0.055±0.09 vs group
2, 0.013±0.02; p=0.113) or between six and twelve months postoperatively (group 1, 0.139±0.14 vs group 2,
0.171±0.14; p=0.567). Twenty-three percent of patients required Nd:YAG capsulotomy at the twelve-month
visit.
CONCLUSIONS: No differences in PCO rates were found between hydrophobic and hydrophilic acrylic square-
edged IOLs in children between five and twelve years of age at one year of follow-up.
KEYWORDS: Posterior Capsule Opacification; Pediatric Cataract; Hydrophilic IOL; Hydrophobic IOL; EPCO.
’ INTRODUCTION
The ideal intraocular lens (IOL) to implant in children
should have good uveal and capsular biocompatibility
(1,2) because the growth of the residual lens epithelial cells
remaining after cataract surgery is faster in children than
in adults, with an increased inflammatory response in
this age group (3-5). Hydrophilic acrylic square-edged
IOLs may benefit children because these lenses have good
uveal biocompatibility, and the presence of the square
edge might compensate for the relatively low capsular
biocompatibility (1,6).
The introduction of IOLs with a sharp edge design has
improved surgical outcomes by inhibiting lens epithelial cell
migration and proliferation through a mechanical barrier
effect that reduces posterior capsule opacification (PCO)
rates in adults (7-13). Most studies involving adults have
found higher PCO rates in those with hydrophilic acrylic
IOLs than in those with hydrophobic acrylic IOLs; however,
many of these studies have included hydrophilic acrylic IOLs
with round edges (1,14). Moreover, it may not be appropriate
to generalize these results to children because the tissue
reactivity in children is different than that in adults. In addi-
tion to the biocompatibility of the materials, postoperative
complications and costs should also be considered when
choosing IOLs (15). The settings of some countries may
influence the choice of IOL types, as hydrophobic IOLs
typically have a higher cost than hydrophilic IOLs.
Although IOL implantation has become increasingly com-
mon in pediatric cataract patients, literature evaluating theDOI: 10.6061/clinics/2020/e1604
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materials from which IOLs are made is scarce. Few publica-
tions have compared polymethylmethacrylate (PMMA) vs
acrylic hydrophobic IOLs (16-18) and PMMA vs hydrophilic
IOLs; furthermore, most of the evaluated IOLs do not have
square edges (19). One recent retrospective study comparing
hydrophobic vs hydrophilic IOLs in children (20) showed
comparable visual and surgical outcomes and equal rates of
PCO. Therefore, this prospective study aimed to compare the
effects of hydrophobic vs hydrophilic acrylic square-edged
IOLs for primary in-the-bag implantation in pediatric cata-
ract patients on the development of PCO at 1 year using the
Evaluation of Posterior Capsule Opacification (EPCO) 2000
system for the first time. Visual outcomes and other compli-
cations were also documented.
’ PATIENTS AND METHODS
This prospective randomized study included children
between five and twelve years of age with unilateral or
bilateral developmental cataracts who underwent cataract
surgery with IOL implantation at the Humberto Castro Lima
Hospital in Salvador, Brazil. Between January 2016 and
December 2016. Informed consent was obtained from the
parents/legal guardians of all participants prior to enroll-
ment. The study followed the tenets of the Declaration of
Helsinki and was approved by the Medical Institutional
Review Board with the approval of the University of São
Paulo, São Paulo, Brazil. It is registered on the National
Institutes of Health Clinical Trials website.A
The exclusion criteria were coexisting ocular disease, sys-
temic diseases, secondary cataracts (trauma, uveitis) and
previous ocular surgery. Patients with poor cooperation due
to neurological delays or difficulty attending follow-up
examinations due to distance (residence more than 250 km
from the hospital) were also excluded. Children under five
years of age were excluded because intraoperative capsu-
lotomy is routinely performed in this age group.
Patients were randomly assigned to either group 1 (hydro-
phobic acrylic square-edged IOLs) or group 2 (hydrophilic
acrylic square-edged IOLs) according to assigned numbers
from a computer-generated randomization program. For
bilateral cataracts, the first operated eye was included in
the randomized group, and the second eye was included in
the other group. Parents/legal guardians and patients were
blinded to the assigned interventions. The sample size was
estimated based on the results of a previous clinical trial
(mean±standard deviation (SD) of the EPCO score: hydro-
phobic group: 0.0±0.13 vs. hydrophilic group: 1.3±1.35)
(21), considering a 95% confidence level and 80% power.
To detect a difference of -1.3 in the EPCO score, the required
sample size was nine patients per group.
Preoperative Assessment
One of two experienced examiners, both of whom were
blinded to the assigned interventions, performed a complete
examination, which included an assessment of visual acuity
(VA), Goldmann applanation tonometry, manifest refraction
and fundoscopy for each child. The types of lens opacities
were assessed with a slit lamp after the induction of
mydriasis (22).
IOLs
The IOL models compared in this study differed in acrylic
material compositions and configurations. Patients in group
1 were treated with an AcrySof SA60AT model (Alcon
Laboratories, Fort Worth, TX, USA), which is a hydrophobic
(acrylate-methacrylate copolymer) IOL, monofocal, 6.0 mm
optic diameter, that is 13.0 mm in overall length, with 0o
haptic angulation, a spherical shape and a continuous square
edge, except at the haptics. Patients in group 2 were treated
with an Akreos Adapt Advanced Optics (AO) model (Bausch
& Lomb, Rochester, NY, USA), which is a hydrophilic (poly-
hydroxyl-ethyl methacrylate/methyl methacrylate copoly-
mer) IOL, monofocal, 6.0 mm optic diameter, 10.5 to 11.0 mm
in overall diameter, with an aspheric shape and a 360o post-
erior barrier edge, except at the 4 optic-haptic junctions. All
IOLs were biconvex and commercially available sharp-edged
designs and foldable single-piece units with an ultraviolet
(UV) light filter (21,23-26).
IOL Power Calculation
The Sanders-Retzlaff-Kraff/theoretical (SRK/T) formula
was used for the IOL power calculation. Immediate post-
operative undercorrection was planned according to the
patient’s age:+1 diopter (D) in children between 5-6 years of
age and emmetropia in patients older than seven years of
age.
Surgical Procedure
All children underwent cataract surgery under general
anesthesia. The pupil was dilated with 1% cyclopentolate and
2.5% phenylephrine. One experienced surgeon (CK) per-
formed all surgeries in both groups using a standardized sur-
gical procedure in both groups. In brief, a temporal 2.75-mm
self-sealing clear corneal incision was made, and trypan blue
was injected. A balanced salt solution (BSS, Alcon, Fort Worth,
TX, USA) containing an epinephrine (1 ml/L) wash and an
ophthalmic viscosurgical device (OVD) (Ophthal-Fill HPMC
2%) were injected into the anterior chamber. A manual
anterior continuous curvilinear capsulorhexis of 5.0 mm in
diameter was created with Utrata forceps. Hydrodissection
was performed, followed by irrigation/aspiration (I/A) of the
lens and cortex and polishing of the anterior capsule. After
insertion of the OVD, the IOL was inserted in-the-bag through
the main incision with an injector, the OVD was aspirated
using I/A, and acetylcholine was injected into the anterior
chamber. At the end of the procedure, an inferior subcon-
junctival steroid injection (dexamethasone 0.4 mg) was
administered, and antibiotic drops were administered in the
operated eye. No sutures were used. There was a 15-day
interval between surgeries in bilateral cases.
The standardized postoperative regimen was as follows:
0.5% moxifloxacin eye drops (Vigamox, Novartis Interna-
tional AG, Switzerland) were administered every six hours
for one week; 1% prednisolone acetate eye drops were
administered every four hours for one week and then
tapered gradually over four additional weeks; and 1%
tropicamide eye drops were administered twice daily for
two weeks.
PCO
Patient evaluations were performed postoperatively at
one, seven and 30 days; once monthly for up to six months;
and every three months thereafter. Digital retroillumination
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images of the posterior capsule of each operated eye were
obtained at one, three, six and 12 months after surgery
through maximally dilated pupils (tropicamide and pheny-
lephrine eye drops were administered once every 10 minutes
for 3 cycles) using a high-resolution digital camera (Canon
EOS 6D with a Canon SLR/D-SLR adapter) mounted on a
slit lamp (Huvitz) under fixed illumination. In those patients
who required capsulotomy, digital retroillumination images
of the posterior capsule were taken at the same visit but
before the Nd:YAG was performed. The PCO images were
imported into EPCO 2000 image analysis software. As
children have an increased risk for capsular phimosis and
opacity of the anterior capsule, the EPCO was conducted
within the capsulorhexis area rather than according to the
optic size of the IOL. The capsulorhexis border was marked,
after which the PCO areas were drawn manually. To avoid
interfering with the results, only IOL optics (without the
haptics) were presented to the examiner to mark the
capsulorhexis in the EPCO program. Dense areas were
identified and actively marked on the computer screen
by the observer. The individual PCO score for each eye
was calculated by EPCO, multiplying the density of the
opacification (graded 0 to 4) by the fractional PCO area
behind the IOL optic. The EPCO program calculated the
density surface mathematically by performing pixel counts.
The EPCO score (scale, 0 to 4) and EPCO area (mm2) were
interpreted by the software. The density of the opacification
was also clinically evaluated with a slit lamp and subjec-
tively graded as 0 (none), 1 (mild), 2 (moderate) or 3 (severe)
at the final visit.
Our primary outcome measures were the mean EPCO
scores at one, three, six and 12 months. We also investigated
the delta (D) values of the EPCO scores between three and six
months and between six and 12 months.
Other Outcome Measures
Postoperative complications, refraction changes, corrected
distance visual acuity (CDVA) at the one-year follow-up and
neodymium:yttrium-aluminum-garnet (Nd:YAG) capsulot-
omy rates were also recorded. Nd:YAG laser capsulotomy
was performed in patients with decreased VA (one or more
lines) according to the clinical evaluation of PCO. If the
patient underwent capsulotomy, the EPCO score was not
applied. The EPCO score was applied to patients before
Nd:YAG laser capsulotomy was necessary. Macular optical
coherence tomography (Zeiss OCT) was performed in all
patients within the first month after surgery. Intraocular
pressure was measured at all visits.
Statistical Analysis
All quantitative data were found to be normally distrib-
uted according to the Kolmogorov-Smirnov test and des-
criptive statistics. Quantitative variables are expressed as
means and SDs. Qualitative variables are expressed as
absolute and relative frequencies. Independent t-tests were
used to compare means between the groups. For intragroup
comparisons of the means at four timepoints (one month,
three months, six months and 12 months), repeated measures
ANOVAwas used. To compare the mean EPCO scores between
three and 12 months and to evaluate the intragroup EPCO
score variation, paired t-tests were used. Statistical Package
for the Social Sciences (version 19.0, SPSS, Inc., Chicago, USA)
for Windows software was used for the statistical analysis.
A p-valueo0.05 was considered statistically significant.
’ RESULTS
Twenty-eight eyes (19 patients) were included in the study.
Twenty-six eyes (13 eyes in each group) were included in the
final analysis. Two selected children (both with unilateral
cataracts) were excluded from the analysis; one moved to
another city, and the other required an intraoperative post-
erior capsulotomy because of a dense cataract with involve-
ment of the posterior capsule. Eight patients (8 eyes) with
unilateral cataracts and nine patients (18 eyes) with bilateral
cataracts were analyzed. No other intraoperative complica-
tions were observed. All patients analyzed underwent IOL
in-the-bag implantation.
Preoperative Demographics
No significant differences were observed in the mean age at
surgery or the gender distribution between the groups (p=0.497
and p=0.619). The mean age at surgery was 7.04±2.47 SD
(range, 5 to 12) years. Of the children analyzed, seven children
(13 eyes) were five years old when they underwent surgery,
three children (3 eyes) were seven years old, three children
(4 eyes) were eight years old, one child (1 eye) was nine years
old, one child (2 eyes) was ten years old and two children (3
eyes) were twelve years old. The most frequent cataract
morphology was nuclear (16, 61.5%), followed by lamellar (5,
19.2%). The mean axial length was 23.30±1.26 mm. Table 1
shows the demographic data of the patients in both groups.
Main Outcomes
A significant increase in the PCO rate was observed in
both groups (po0.05) at the one-year follow-up. Table 2
shows the comparisons between the EPCO scores at three,
six and twelve months within and between the two groups.
Table 1 - Comparisons of the baseline demographic data between the groups.
Mean±SD (Range)
Parameter Group 1 Group 2 p-value
Eyes (n) 13 13 _
Male n (%) 11 (84.6) 10 (76.9) 0.619**
Age at cataract surgery (y) 6.69±2.28 (5, 12) 7.38±2.69 (5, 12) 0.487*
IOL power (D) 20.50±2.48 (16.00, 24.50) 19.73±2.73 (14.50, 25.00) 0.460*
Axial length (mm) 23.07±1.27 (21.64, 25.16) 23.52±1.26 (21.79, 25.79) 0.374*
CDVA before surgery (LogMAR) 0.87±0.33 (0.5, 1.3) 0.83±0.33 (0.3, 1.3) 0.766*
CDVA at final follow-up (LogMAR) 0.29±0.18 (0.0, 0.6) 0.26±0.18 (0.0, 0.6) 0.675*
SE at final follow-up (D) 0.38±1.11 (-1.00, 2.75) 0.07±0.92 (-1.50, 1.50) 0.452*
SD=standard deviation; y=years; D=diopters; SE=spherical equivalent; CDVA=corrected distance visual acuity; mm=millimeters; IOL=intraocular lens;
LogMAR=logarithm of the minimum angle of resolution; **Chi-square; *Independent t-test.
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The EPCO score was available for all eyes included in the
study. The mean EPCO score at one month was 0.0 in both
groups. No statistically significant difference was found
when the PCO rates were compared between the two groups
(p=0.881) at the one-year follow-up or at the final follow-up
(p=0.902). The EPCO score evaluation by group during the
follow-up period is shown in Figure 1 (at three months,
group 1 (0.007±0.016) vs group 2 (0.008±0.014) (p=0.830); at
six months, group 1 (0.062±0.103) vs group 2 (0.021±0.023)
(p=0.184); at twelve months, group 1 (0.200±0.193) vs group
2 (0.192±0.138) (p=0.902)).
The EPCO score change (D) between three and six months
was 0.055±0.09 in group 1 and 0.013±0.02 in group 2
(p=0.113). The D between six months and twelve months was
0.139±0.14 in group 1 and 0.171±0.14 in group 2 (p=0.567).
No patient required capsulotomy prior to the 12-month
postoperative visit. Six eyes (23.07%) required Nd:YAG
capsulotomy at the twelve-month visit; four were in group
1 (p=0.097). However, no significant differences were obser-
ved between the two groups. No complications following
capsulotomy were observed. Figure 2 illustrates the evolu-
tion and development of PCO in one eye that required
treatment. Five eyes with PCO had pearl-type PCO, and one
eye had fibrotic-type PCO. The clinical evaluations revealed
mild PCO in nine eyes, moderate PCO in four eyes, severe
PCO in one eye and no PCO in the remaining eyes at the last
visit. Among patients who needed Nd:YAG capsulotomy,
two eyes had other complications, one eye had synechiae,
and one eye had pigment deposits. The mean VA in the six
patients who needed capsulotomy after the procedure was
0.33 (0 to 0.6±0.26).
VA and Refraction Outcomes
All the patients benefited from the surgery. The mean
CDVA before surgery was 0.84±0.32 LogMAR. A sig-
nificant improvement in VA was observed after surgery
(p=0.000). One month after surgery, the mean CDVA was
0.27±0.18 LogMAR, and the mean spherical equivalent
(SE) was 0.23±1.01 D. No statistically significant differ-
ence in CDVA was observed at the one-year follow-up
between the two groups (p=0.675). The mean IOL power
was 20.11±2.58 D.
Table 2 - EPCO score in each group during the follow-up period.
Mean±SD
Timepoint Group 1 (13 eyes) Group 2 (13 eyes) p-value
3 months 0.007±0.016 0.008±0.014 0.830*
6 months 0.062±0.103 0.021±0.023 0.184*
12 months 0.200±0.193 0.192±0.138 0.902*
p-value 0.002a 0.000a
SD=standard deviation; *Independent t-test; a=ANOVA test.
p* intergroup.
pa intragroup.
Figure 2 - Evolution of pearl-type PCO in one eye that required treatment (A: three; B: six; and C and D: twelve months postoperatively.
The opacification areas (D) were color coded according to their densities in the EPCO software (0: no color; I: light blue; II: intermediate
blue; III: dark blue, IV: there were none in this case) and (E) after Nd:YAG capsulotomy.
Figure 1 - Evaluation of the Posterior Capsule Opacification (EPCO) score by group during the follow-up period. At one month: group 1
(0.007±0.016) vs group 2 (0.008±0.014) (p=0.830); at six months: group 1 (0.062±0.103) vs group 2 (0.021±0.023) (p=0.184); and at
twelve months: group 1 (0.200±0.193) vs group 2 (0.192±0.138) (p=0.902).
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Other postoperative complications included posterior
synechiae (two eyes in group 2), pigment deposits on the
IOL (one eye in group 1 and two eyes in group 2) and IOL
decentration (one eye in group 2) (p=0.160). Most of these
complications occurred in children younger than six years of
age at the time of surgery. The patient with IOL decentration
required an additional surgery. No glaucoma was observed,
and no cystoid macular edema was observed on macular
optical coherence tomography. Additionally, in this study, no
IOL glistening was noted, and there were no intraoperative
challenges or complications.
’ DISCUSSION
Regardless of efforts to delay the onset of PCO, it is a
common complication following cataract surgery (19,27).
PCO has a multifactorial pathogenesis, and patient age and
IOL design play a crucial role in its development (28). This
study compared the effects of two different commercially
available acrylic square-edged IOLs on the PCO rates in
children older than five years of age for the first time. Our
study suggests that the IOL material did not influence the
PCO rates in patients at the ages studied. These results differ
from those of cataract surgery in adults, as PCO formation in
children is much more aggressive than in adults; thus, the
IOL design/material is likely to be less important than
the surgical technique is in the prevention of PCO formation.
In addition, this study observed that PCO tends to occur
earlier in children, even in those over five years old, than in
adults, as more than 20% of the evaluated eyes required Nd:
YAG capsulotomy at the one-year postoperative visit.
In a retrospective study, Kleimann et al. (29) showed that
14% of children aged five months to 14 years old developed
PCO at 47±21 months when a hydrophilic acrylic material
was used; most of the implanted IOL models had a 360o
square-edged design. Kleimann et al. suggested that a pro-
spective study to compare PCO rates between hydrophilic
and hydrophobic acrylic material in pediatric patients was
needed because the existing literature on the topic is scarce.
Previous reports showed that square-edged IOLs pre-
vented PCO (7,30). In adults, Kahraman et al. (24) reported a
PCO rate of 0.23±0.36 as measured by EPCO software in
adults at the three-year follow-up after implantation of the
same hydrophobic acrylic IOL used in this study. In our study,
a PCO rate of 0.20±0.19 was measured by EPCO software at
the one-year follow-up. In addition, 23% of patients under-
went Nd:YAG capsulotomy in the first year of follow-up;
however, no significant differences were observed between
the two groups. This result suggests that children develop
PCO faster than adults, even when square-edged IOLs are
used, which might be explained by the particular character-
istics and behavior of children’s eyes. Considering EPCO
scores, Vasavada et al. (21) compared the same IOLs that we
used in adults, and after one year, no statistically significant
difference in the EPCO scores was found. During three years
of follow-up, even though a higher PCO rate was observed in
the hydrophilic group than in the hydrophobic group, only
16% of patients underwent Nd:YAG capsulotomy.
Regarding pediatric cataracts, only a few studies have
compared PCO rates in patients treated with different IOL
materials; moreover, only clinical PCO has been described. In
a prospective study by Bhusal et al., children ranging in age
from one month to eight years who underwent cataract
surgery and primary posterior capsulotomy were examined.
They found a higher number of PCO cases after treatment
with hydrophobic acrylic IOLs than with silicone IOLs (both
with square edges) after one year of follow-up; however, the
difference was not significant (25). Panahi-Bazaz et al. (19)
prospectively compared PMMA IOLs to hydrophilic acrylic
IOLs with no sharp edges in children younger than six years
old who underwent cataract surgery with capsulotomy and
anterior vitrectomy. They reported PCO, which was not
dependent on the IOL material used, in two children during
more than one year of follow-up. Pigment deposits on the
IOL were the only complication with a significant difference
between the groups, exhibiting a lower rate in the acrylic
group than in the PMMA group. Wilson (28), Ram (18) and
Aasuri (31) compared PMMA and hydrophobic acrylic IOLs
in a retrospective study and found lower PCO and uveal
inflammation rates associated with acrylic IOLs than with
PMMA IOLs. In our study, more cases of pigment deposits
on the IOL were found in the hydrophilic group than in the
hydrophobic group, even though the difference was not
significant. Additionally, although statistical significance was
not reached, more cases of synechiae and IOL decentration
were also observed in this group. One possible reason for
decentration is that hydrophilic acrylic IOLs are less rigid
than hydrophobic acrylic IOLs.
In children older than five years, it is possible to leave the
posterior capsule intact intraoperatively, and Nd:YAG laser
capsulotomy can be performed if required because these
patients have a lower amblyopia risk and lower PCO rates
than those in younger children. The ideal age to perform an
intraoperative capsulotomy has not yet been determined
(5,32). In this study, 66.6% of Nd:YAG capsulotomies were
performed in children younger than six years old, including
those treated with both types of IOL materials, suggesting
that younger children have higher rates of PCO than older
children. Nd:YAG capsulotomies were successfully per-
formed in these children. It may be interesting to perform
posterior capsulotomy during surgery, at least in children
undergoing cataract surgery at under six years of age.
However, additional studies involving different IOL types
and surgical techniques are needed to determine the optimal
age group for this procedure.
As this was a pioneering study, the implanted IOLs and
the age range of the included children were carefully
selected. We chose IOLs for which the microstructure of the
edge has already been studied microscopically. In addition,
we included only children older than five years of age, as
younger patients necessarily require intraoperative capsu-
lotomy, which would prevent the documentation of PCO via
the software (26). According to Werner et al., the square
edges of hydrophilic IOLs have variable microedge struc-
tures, and this factor cannot be controlled for in prospective
studies. Aweakness of this study is the small number of eyes
included; however, the sample size calculation procedure
was followed. As such, the present conclusions should be
interpreted with great caution.
The current study is the first to quantify PCO rates in
children using software and prospectively compare two
acrylic square-edged IOLs made of different materials. No
significant difference in the PCO rate was observed between
children treated with either type of IOL, but a large number
of children required Nd:YAG capsulotomies, leading to the
conclusion that intraoperative posterior capsulorhexis is a
good option at least in children up to six years old. We will
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continue to follow these children for up to five years after
their operations. In addition, an increased number of other
complications was observed in the hydrophilic material
group. Future clinical trials with an extended follow-up
period, a larger number of children and different IOL designs
are necessary.
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